Search Results - "Zhen, Sisi"

P1527: ASSESSMENT OF RISK FACTORS AND ANTIMICROBIAL THERAPY FOR CARBAPENEM‐RESISTANT PSEUDOMONAS AERUGINOSA BLOODSTREAM INFECTIONS IN HEMATOLOGICAL PATIENTS by Chen, Zhangjie, Zhen, Sisi, Zhao, Yuanqi, Feng, Sizhou

Get full text

P570: VENETOCLAX PLUS HYPOMETHYLATING AGENTS VERSUS INTENSIVE CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE OF MYELOID MALIGNANCIES AFTER ALLO-HSCT by Chen, Zhangjie, Zhen, Sisi, Chen, Xin, Feng, Sizhou

Get full text

Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Pseudomonas aeruginosa in patients with hematological diseases by Zhen, Sisi, Zhao, Yuanqi, Chen, Zhangjie, Zhang, Tingting, Wang, Jieru, Jiang, Erlie, Zhang, Fengkui, Mi, Yingchang, Zhu, Xiaofan, Han, Mingzhe, Xiao, Zhijian, Wang, Jianxiang, Feng, Sizhou

“…Infections caused by carbapenem-resistant (CRPA) are related to higher mortality. The objective of this study was to explore clinical outcomes of CRPA…”
Get full text

Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae in hematological patients: assessment of risk factors for mortality and treatment options by Zhang, Lining, Zhen, Sisi, Shen, Yuyan, Zhang, Tingting, Wang, Jieru, Li, Jia, Lin, Qingsong, Xiao, Zhijian, Zheng, Yizhou, Jiang, Erlie, Han, Mingzhe, Wang, Jianxiang, Feng, Sizhou

“…Bloodstream infection (BSI) caused by Carbapenem-Resistant Enterobacteriaceae (CRE) are associated with poor outcomes in hematological patients. The aim of…”
Get full text

Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT by Chen, Zhangjie, Zhen, Sisi, Zhang, Tingting, Shen, Yuyan, Pang, Aiming, Yang, Donglin, Zhang, Rongli, Ma, Qiaoling, He, Yi, Wei, Jialin, Zhai, Weihua, Chen, Xin, Jiang, Erlie, Han, Mingzhe, Feng, Sizhou

“…Since allogeneic stem cell transplantation (allo-HSCT) is considered one of the curative treatments for acute myeloid leukemia (AML) and myelodysplastic…”
Get full text

P1290: UPFRONT ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN PROVIDE SURVIVAL BENEFIT VERSUS HYPOMETHYLATING AGENT IN MYELODYSPLASTIC SYNDROME WITH INCREASED BLASTS I (MDS‐IBI) by Runzhi, MA, Zhen, Sisi, Wang, Jieru, Liu, LI, Jiang, Erlie, Han, Mingzhe, Xu, Zefeng, Xiao, Zhijian, Feng, Sizhou

Get full text

Update of clinical application in ceftazidime–avibactam for multidrug-resistant Gram-negative bacteria infections by Zhen, Sisi, Wang, Hui, Feng, Sizhou

“…Purpose Multidrug-resistant Gram-negative bacteria (MDR-GNB) have become a major global public health threat. Ceftazidime–avibactam (CAZ–AVI) is a newer…”
Get full text

Ceftazidime-Avibactam in the Treatment of Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacteria in Hematological Patients: Experience in a Single Center by Zhen, Sisi, Lin, Qingsong, Zhai, Weihua, Jiang, Erlie, Feng, Sizhou

“…Background: Experience with ceftazidime-avibactam (CAZ-AVI) for bacteremia caused by carbapenem-resistant Enterobacterales (CRE) and Pseudomonas aeruginosa…”
Get full text

Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in Patients with Hematologic Diseases: A Single-Center Retrospective Study by Wang, Jieru, Zhen, Sisi, Jiang, Erlie, Feng, Sizhou

“…Mucormycosis is a serious disorder with severe inflammatory response and tissue damage caused by the infection of Mucorales. Mucormycosis usually occurs in…”
Get full text

Recipient Resident Macrophage Plays a Crucial Role in Acute Graft-Versus-Host-Disease after Allogeneic Stem Cell Transplantation By Regulation of Damage-Associated Molecular Pattern Phagocytosis by Shen, Yuyan, Zhang, Tingting, Chen, Zhangjie, Zhen, Sisi, Wang, Jieru, Jiang, Erlie, Liao, Xudong, Feng, Sizhou

“…Introduction Evidence shows allogeneic hematopoietic stem cell transplantation (alloHSCT) provides life-sustaining therapy for many hematologic malignancies…”
Get full text

Upfront Allogeneic Hematopoietic Stem Cell Transplantation Can Provide Survival Benefit Versus Hypomethylating Agent in Myelodysplastic Syndrome with Increased Blasts I (MDS-IB I) by Ma, Runzhi, Zhen, Sisi, Liu, Li, Wang, Jieru, Jiang, Erlie, Feng, Sizhou

“…Introduction Myelodysplastic syndrome (MDS) is a group of clonal disorders of hematopoietic stem cell. Survival would be significantly shortened if excessive…”
Get full text

Allogeneic stem cell transplantation can prolong the survival of patients with NUP98-rearranged acute myeloid leukemia by Shen, Yuyan, Zhang, Tingting, Zhang, Lining, Zhen, Sisi, Chen, Zhangjie, Zhang, Rongli, Yang, Donglin, Wei, Jialin, He, Yi, Jiang, Erlie, Feng, Sizhou

Get full text

Pseudomonas aeruginosa bloodstream infection in patients with hematological diseases: Clinical outcomes and prediction model of multidrug-resistant infections by Zhao, Yuanqi, Lin, Qingsong, Zhang, Tingting, Zhen, Sisi, Wang, Jieru, Jiang, Erlie, Mi, Yingchang, Qiu, Lugui, Han, Mingzhe, Wang, Jianxiang, Feng, Sizhou

“…•Long-term antibiotic use linked to multidrug-resistant infections.•Bloodstream infection prognosis is closely related to time to effective treatment.•The use…”
Get full text

Ceftazidime-avibactam in the treatment of bacteremia due to carbapenem-resistant gram-negative bacteria in hematological patients: Experience in a single center by Zhen, Sisi, Lin, Qingsong, Chen, Zhangjie, Shen, Yuyan, Chen, Xin, Pang, Aiming, Yang, Donglin, Zhang, Rongli, Ma, Qiaoling, He, Yi, Wei, Jialin, Zhai, Weihua, Jiang, Erlie, Han, Mingzhe, Wang, Jianxiang, Feng, Sizhou

“…Limited experience exists with ceftazidime-avibactam (CAZ-AVI) in treating bacteremia caused by carbapenem-resistant Enterobacterales (CRE) and Pseudomonas…”
Get full text

The enhanced immune response of PCV-2 vaccine using Rehmannia glutinosa polysaccharide liposome as an adjuvant by Huang, Yee, Liu, Zhenguang, Bo, Ruonan, Xing, Jie, Luo, Li, Zhen, Sisi, Niu, Yale, Hu, Yuanliang, Liu, Jiaguo, Wu, Yi, Wang, Deyun

“…•The particle size and PDI value of Rehmannia glutinosa polysaccharide liposome encapsulated with PCV-2 showed little change within 30 days, which indicated…”
Get full text

P570: VENETOCLAX PLUS HYPOMETHYLATING AGENTS VERSUS INTENSIVE CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE OF MYELOID MALIGNANCIES AFTER ALLO‐HSCT by Chen, Zhangjie, Zhen, Sisi, Chen, Xin, Feng, Sizhou

Get full text